The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease
Author:
Funder
Queensland Government
National Health and Medical Research Council
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference35 articles.
1. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk);Bonaca;Circulation,2018
2. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry;Cacoub;Atherosclerosis,2009
3. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions;J Vasc Surg,2007
4. The cost-effectiveness of PCSK9 inhibitors—the Australian healthcare perspective;Kumar;Int J Cardiol,2018
5. Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study;Ko;J Am Heart Assoc,2018
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease;JAMA Surgery;2024-08-21
2. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication;European Journal of Vascular and Endovascular Surgery;2024-01
3. Contemporary Medical Management of Peripheral Arterial Disease;Cardiovascular Drugs and Therapy;2023-11-02
4. Peripheral Artery Disease: Underappreciated Impact and Residual Cardiovascular Risk Despite Revascularization;Clinical Therapeutics;2023-11
5. Rates of Stroke in Patients With Different Presentations of Carotid Artery Stenosis;European Journal of Vascular and Endovascular Surgery;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3